Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 61.86
(1.51%)
CNY 61.86
(1.51%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 188.59 Million CNY | -2.62% |
| 2022 | 193.65 Million CNY | -49.55% |
| 2021 | 383.84 Million CNY | 210.24% |
| 2020 | 123.72 Million CNY | 127.02% |
| 2019 | 54.5 Million CNY | 28.06% |
| 2018 | 42.55 Million CNY | 47.57% |
| 2017 | 28.84 Million CNY | 56.13% |
| 2016 | 18.47 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 152.69 Million CNY | -4.74% |
| 2024 Q1 | 161.87 Million CNY | -14.17% |
| 2024 Q2 | 160.28 Million CNY | -0.98% |
| 2023 Q3 | 187.63 Million CNY | -5.18% |
| 2023 FY | 188.59 Million CNY | -2.62% |
| 2023 Q4 | 188.59 Million CNY | 0.51% |
| 2023 Q2 | 197.88 Million CNY | 0.65% |
| 2023 Q1 | 196.6 Million CNY | 1.52% |
| 2022 FY | 193.65 Million CNY | -49.55% |
| 2022 Q3 | 418.23 Million CNY | -4.95% |
| 2022 Q4 | 193.65 Million CNY | -53.7% |
| 2022 Q2 | 440 Million CNY | -5.24% |
| 2022 Q1 | 464.32 Million CNY | 20.97% |
| 2021 Q2 | 147.79 Million CNY | 14.68% |
| 2021 FY | 383.84 Million CNY | 210.24% |
| 2021 Q1 | 128.87 Million CNY | 4.17% |
| 2021 Q4 | 383.84 Million CNY | 86.75% |
| 2021 Q3 | 205.54 Million CNY | 39.07% |
| 2020 Q3 | 81.4 Million CNY | 6.71% |
| 2020 Q2 | 76.28 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 123.72 Million CNY | 127.02% |
| 2020 Q4 | 123.72 Million CNY | 51.99% |
| 2019 Q4 | 54.5 Million CNY | 0.0% |
| 2019 FY | 54.5 Million CNY | 28.06% |
| 2018 FY | 42.55 Million CNY | 47.57% |
| 2017 FY | 28.84 Million CNY | 56.13% |
| 2016 FY | 18.47 Million CNY | 0.0% |